Evidence map›Paper›PMID 30224169›Full record

ReviewInternational journal for parasitology. Drugs and drug resistance2018

TRP channels as potential targets for antischistosomals.

Swarna Bais, Robert M Greenberg

Open access · goldAbstract readReview
In one paragraph

Review in International journal for parasitology. Drugs and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. TRPA1 InfluencesInternational journal of molecular sciences · 2024
    Article
  2. Article
  3. Review
  4. Schistosomiasis.Advances in experimental medicine and biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Schistosome TRP channels: An appraisal.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  10. Review
  11. Article
  12. Review
  13. Anthelmintics - From Discovery to Resistance III (Indian Rocks Beach, FL, 2018).International journal for parasitology. Drugs and drug resistance · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Swarna BaisDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia PA 19104, USA.
Robert M GreenbergDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia PA 19104, USA. Electronic address: rgree@vet.upenn.edu.
University of Pennsylvania · US

Funding

Physiological roles of schistosome TRP ion channels with atypical pharmacologyR01AI123173 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HERBERT, DE'BROSKI R · 2017 to 2021
$2.0M
Discovery of novel antiparasitics that target a pharmacologically atypical schistosome Transient Receptor Potential (TRP) ion channelR21AI132912 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENBERG, ROBERT M · 2017 to 2018
$443k
NIAID NIH HHS R01 AI123173NIAID NIH HHS R21 AI132912
6 · The paper itself

Abstract

Ion channels are membrane protein complexes that underlie electrical excitability in cells, allowing ions to diffuse through cell membranes in a regulated fashion. They are essential for normal functioning of the neuromusculature and other tissues. Ion channels are also validated targets for many current anthelmintics, yet the properties of only a small subset of ion channels in parasitic helminths have been explored in any detail. Transient receptor potential (TRP) channels comprise a widely diverse superfamily of ion channels with important roles in sensory signaling, regulation of ion homeostasis, organellar trafficking, and other functions. There are several subtypes of TRP channels, including TRPA1 and TRPV1 channels, both of which are involved in, among other functions, sensory, nociceptive, and inflammatory signaling in mammals. Several lines of evidence indicate that TRPA1-like channels in schistosomes exhibit pharmacological sensitivities that differ from their mammalian counterparts and that may signify unique physiological properties as well. Thus, in addition to responding to TRPA1 modulators, schistosome TRPA1-like channels also respond to compounds that in other organisms modulate TRPV1 channels. Notably, TRPV channel genes are not found in schistosome genomes. Here, we review the evidence leading to these conclusions and examine potential implications. We also discuss recent results showing that praziquantel, the current drug of choice against schistosomiasis, selectively targets host TRP channels in addition to its likely primary targets in the parasite. The results we discuss add weight to the notion that schistosome TRP channels are worthy of investigation as candidate therapeutic targets.

Indexed as

Drug Delivery SystemsAnimalsAnthelminticsHost-Parasite InteractionsHumansMicePraziquantelSchistosomaSchistosomiasisTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPV Cation ChannelsAnthelminticsPraziquantelTransient Receptor Potential ChannelsTRPA1 Cation ChannelTRPV Cation ChannelsCapsaicinIon channelsPraziquantelSchistosomaSchistosomiasisTRPA1TRP channelsTRPV1

Identifiers

PMID30224169
PMCPMC6287577
OpenAlexW2891947732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.